| Literature DB >> 34757987 |
Emily A Arnold1, Parya Saberi1, Jeffrey O Wong1, Lance M Pollack1, Torsten B Neilands1, Michael Benjamin2, Gloria Lockett2, Susan M Kegeles1.
Abstract
BACKGROUND: Black and Latinx sexual minority youth are disproportionately affected by HIV. The House Ball and gay family communities encompass sexual and ethnic minority youth who form chosen families that promote protective HIV-related health behaviors. We conducted a small-scale trial of the We Are Family intervention, leveraging these existing social dynamics to address HIV.Entities:
Mesh:
Year: 2021 PMID: 34757987 PMCID: PMC8579983 DOI: 10.1097/QAI.0000000000002805
Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN: 1525-4135 Impact factor: 3.731
We Are Family Cohort Characteristics at Baseline (N = 118)
| Characteristic | n (%) | Characteristic | n (%) |
| Age | Income past month | ||
| 19–24 | 23 (19.5) | < $250 | 13 (11.0) |
| 25–29 | 39 (33.1) | $250-$499 | 10 (8.5) |
| 30–34 | 21 (17.8) | $500-$999 | 19 (16.1) |
| 35–39 | 20 (16.9) | $1000-$1999 | 29 (24.6) |
| 40+ | 15 (12.7) | $2000-$3000 | 25 (21.2) |
| > $3000 | 22 (18.6) | ||
| Hispanic Ethnicity | |||
| Yes | 38 (32.2) | Homeless in past year | |
| No | 80 (67.8) | Yes | 27 (22.9) |
| No | 91 (77.1) | ||
| Education | |||
| < High school diploma | 12 (10.2) | History of incarceration | |
| High school diploma/GED | 25 (21.2) | Never | 65 (55.1) |
| Some college/votech school | 53 (44.9) | >6 months ago | 49 (41.5) |
| College degree | 28 (23.7) | In past 6 mo | 4 (3.4) |
| Currently in school | Identify as transwoman | ||
| Yes | 21 (17.8) | Yes | 38 (32.2) |
| No | 97 (82.2) | No | 80 (67.8) |
| Employment status | HIV serostatus | ||
| Full-time | 50 (42.4) | HIV-positive | 34 (28.8) |
| Part-time | 29 (24.6) | HIV-negative | 82 (69.5) |
| Sometimes | 15 (12.7) | Unknown/refuse to answer | 2 (1.7) |
| Unemployed | 24 (20.3) |
Mean (SD) = 31.1 (8.6), Range 19-67.
Baseline to Follow-Up Change in Outcomes for Total Sample (N = 118)
| Outcome | Range | Baseline, Mean/% | Follow-Up, Mean/% | Parameter Estimate | 95% Confidence Interval |
|
| # Times condomless anal int. Past 3 Months | 0–106 | 6.67 | 7.37 | IRR = 0.90 | 0.65 to 1.24 | 0.529 |
| Any condomless anal intercourse past 3 Months | 0–1 | 74.6% | 66.7% | OR = 0.47 | 0.21 to 1.04 | 0.064 |
| Self-efficacy for safer sex scale score | 4–20 | 17.06 | 17.39 | b = 0.38 | −0.08 to 0.84 | 0.106 |
| HIV-related stigma scale score | 5–25 | 17.25 | 16.75 | b = −0.48 | −1.31 to 0.35 | 0.256 |
| Medical mistrust scale score | 1–4 | 2.73 | 2.94 | b = 0.21 | 0.08 to 0.34 | 0.002 |
| # Social alters who are HIV health supportive | 0–5 | 3.44 | 3.19 | b = −0.23 | −0.60 to 0.14 | 0.228 |
Results are based on 50 imputations.
IRR, incidence rate ratio from random-intercepts negative binomial regression model; OR, odds ratio from random-intercepts logistic regression model; b, unstandardized regression coefficient from random-intercepts linear regression model.
Baseline to Follow-Up Change in Outcomes for HIV-Negative Participants (n = 82)
| Outcome | Range | Baseline, % | Follow-Up, % | Parameter Estimate | 95% Confidence Interval |
|
| Tested for HIV in past 6 months | 0–1 | 80.7% | 87.2% | OR = 2.27 | 0.71 to 7.26 | 0.166 |
| Currently taking PrEP | 0–1 | 27.7% | 24.3% | OR = 0.55 | 0.17 to 1.82 | 0.327 |
| PrEP-adherent past 6 months | 0–1 | 9.8% | 12.2% | OR = 1.75 | 0.42 to 7.28 | 0.443 |
| Extremely likely to use PrEP in next 6 months | 0–1 | 59.0% | 55.4% | OR = 0.66 | 0.25 to 1.74 | 0.401 |
| Extremely likely use condoms when bottoming | 0–1 | 57.8% | 59.0% | OR = 1.19 | 0.48 to 2.97 | 0.704 |
Results are based on 50 imputations.
IRR, incidence rate ratio from random-intercepts negative binomial regression model; OR, odds ratio from random-intercepts logistic regression model; b, unstandardized regression coefficient from random-intercepts linear regression model.
Baseline to Follow-Up Change in Outcomes for HIV-Positive Participants (n = 34)
| Outcome | Range | Baseline, Mean/% | Follow-Up, Mean/% | Parameter Estimate | 95% Confidence Interval |
|
| HIV index of engagement scale score | 10–50 | 41.67 | 42.44 | b = 0.11 | −2.34 to 2.56 | 0.930 |
| Received HIV primary care in past 6 Months | 0–1 | 64.5% | 78.8% | OR = 3.41 | 0.67 to 17.39 | 0.139 |
| Received HIV primary care 2+ times past 6 MO. | 0–1 | 41.9% | 60.6% | OR = 2.18 | 0.77 to 6.21 | 0.142 |
| Currently taking ART | 0–1 | 80.6% | 75.0% | OR = 0.35 | 0.04 to 3.03 | 0.343 |
| ART-adherent in past 30 Days | 0–1 | 22.6% | 28.1% | OR = 1.32 | 0.30 to 5.82 | 0.712 |
| ART-adherent in past 6 Months | 0–1 | 41.9% | 43.8% | OR = 0.92 | 0.15 to 5.66 | 0.929 |
| Virally suppressed (adjusted for HIV adherence) | 0–1 | 21.9% | 27.3% | OR = 1.37 | 0.37 to 5.06 | 0.632 |
Results are based on 50 imputations.
IRR, incidence rate ratio from random-intercepts negative binomial regression model; OR, odds ratio from random-intercepts logistic regression model; b, unstandardized regression coefficient from random-intercepts linear regression model.